Latikort - glucocorticosteroid (GCS) for external use.
Release form and composition
Latikort dosage forms:
- Solution for external use of 0.1%: transparent, without sediment and mechanical impurities, colorless, with the smell of isopropyl alcohol (20 ml each in plastic bottles, 1 bottle in a cardboard box);
- Cream for external use 0.1%: homogeneous, white (15 g in aluminum tubes, in a cardboard bundle 1 tube);
- Ointment for external use 0.1%: transparent, colorless, oily consistency (15 g in aluminum tubes, in a cardboard bundle 1 tube).
Active ingredient - hydrocortisone butyrate: in 1 ml of solution, 1 g of cream and ointment - 1 mg.
- Solution: glycerol, povidone, citric acid, sodium citrate, isopropanol, purified water;
- Cream: white petrolatum, liquid paraffin, cetostearyl alcohol, cetomacrogol, citric acid, sodium citrate, methyl parahydroxybenzoate, purified water;
- Ointment: Vaseline white.
Indications for use
Uninfected skin diseases, occurring with excessive keratinization, sensitive to local GCS:
- Contact eczema;
- Atopic dermatitis;
- Lichen planus;
- Seborrheic dermatitis.
Also Laticort is effective for insect bites.
- Violation of the integrity of the skin (wounds and ulcers);
- Perioral dermatitis;
- Acne vulgaris and rosacea;
- Viral, fungal and bacterial infections of the skin;
- Skin tumors;
- Tuberculous or syphilitic skin lesions;
- Post-vaccination period;
- Children up to 6 months, with itching in the anus - up to 12 years;
- Hypersensitivity to the drug.
It is not recommended to apply Laticort in the first trimester of pregnancy.
Relative (special caution required):
- Tuberculosis (systemic lesion);
- Atrophic conditions of the skin, especially in the elderly.
Dosing and Administration
All dosage forms Latikorta intended for external use.
In a small amount of the drug should be applied to the affected skin 1-3 times a day. Treatment can last from 1 to 3 weeks. Weekly dose should not exceed 60 g.
To improve the penetration of the drug, it is recommended to apply it with massaging movements.
For diseases characterized by a resistant course, for example, when localized psoriatic plaques are localized on the knees and elbows, it is recommended to use Laticort under an occlusive dressing.
Mostly Latikort is well tolerated, side effects, if they occur, rarely, while they are reversible, usually it is skin irritation.
When applying the drug on the surface of a large area and / or long-term use, as well as using occlusive dressings, in some cases prickly heat, hypopigmentation, folliculitis, acne-like changes, skin atrophy, stria, secondary skin infections, hypertrichosis are possible.
Sometimes allergic contact dermatitis occurs.
In the form of Laticort ointment, it is not recommended to use for lichenification (thickening of the skin) and sub-acute inflammatory conditions.
During pregnancy, the drug is prescribed only if, according to the doctor, the expected benefits for the expectant mother outweigh the possible risks to the fetus. At the same time, it is possible to apply the product only to small areas of skin, and treatment should be carried out in short courses.
During lactation, Laticort can be applied, but on a small surface of the skin, with the exception of the mammary gland.
In childhood, there is a high risk of suppressing the function of the adrenal cortex, reducing the excretion of growth hormone. Therefore, with prolonged treatment, control over plasma cortisol levels, body weight and height of the child is necessary.
When applying the drug under occlusive dressings (including under a diaper, diaper) or on the face, it is recommended to use the minimum dose, since may increase the absorption of hydrocortisone butyrate. Treatment should be short and be carried out under the supervision of a physician.
Although the use of Laticort in high doses and / or over a long period, especially under occlusive dressings, may cause an increase in plasma cortisol concentration, this phenomenon is never accompanied by a decrease in the reactivity of the pituitary-adrenal system. After discontinuation of the drug, cortisol production is normalized.
In the case of the development of a secondary fungal or bacterial infection, an external antifungal or antibacterial agent is additionally prescribed.
When applying Latikort on the skin, the risk of side effects, such as skin atrophy, perioral dermatitis and telangiectasia, increases.
If within 7 days of treatment the improvement does not occur or, on the contrary, there is worsening, you should consult with your doctor. The same must be done if the symptoms of the disease recur several days after discontinuation of the drug.
When applying means you need to be careful to prevent it from falling into the eyes.
Negative impact on the severity of psychophysical reactions and the ability to concentrate Laicort does not have.
Information on the pharmaceutical and pharmacological interaction of Latikort with other drugs is missing.
Terms and conditions of storage
Store at a temperature not exceeding 25 ° C out of the reach of children.
Shelf life - 3 years.